𝔖 Bobbio Scriptorium

✦ LIBER ✦

1–58 Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Book ID: 123218520
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 78 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80085-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1–57 Effects of Tamoxifen vs Raloxifene

1–57 Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Session 6 Primary prevention of breast c

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S15. The US breast cancer-prevention trials (NSABP-P1, MORE, STAR)

✍ V. Vogel; D. Wickerham; J. Costantino; W. Cronin; N. Wolmark 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 76 KB